✦ LIBER ✦

Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials

✍ Scribed by Mimeault, Murielle; Batra, Surinder K.

Book ID: 118747942
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 994 KB
Volume: 18
Category: Article
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2012.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in molecular carcinogenesis: cu

Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs

✍ Anita F.W. Frijhoff; Claudio J. Conti; Adrian M. Senderowicz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract Survival of patients with advanced solid tumors has not significantly improved over the past 30 years. Although molecularly targeted anticancer drugs offer promise, few drugs make it through the end of the Food and Drug Administration approval process. Animal models that more closely re

Construction and validation of a detaile

Construction and validation of a detailed kinetic model for glycolysis in the asexual stage of Plasmodium falciparum; application for drug target identification

✍ J. Snoep; G. Penkler; M. Rautenbach 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 59 KB

TCT-36: Derivation and Validation of a R

TCT-36: Derivation and Validation of a Risk Model for Predicting Clinically-Driven Target Lesion Revascularization in Drug Eluting Stents

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 174 KB

[ACS Symposium Series] Galectins and Dis

[ACS Symposium Series] Galectins and Disease Implications for Targeted Therapeutics Volume 1115 || Translational Rational for the Clinical Development of OTX-008: A Novel Drug That Inhibits Galectin-1 Expression in Human Cancer Models

✍ Klyosov, Anatole A.; Traber, Peter G. 📂 Article 📅 2012 🏛 American Chemical Society ⚖ 244 KB